Skip to content

Clinical trials

Osteoarthritis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoarthritis Country / region: China Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20091
20101
20112
20122
20132
20145
20154
20163
20175
20184
20191
20212
20225
20235
20242
202512
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting11
Unknown status8
Not yet recruiting7
Terminated5
Active, not recruiting4
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Smith & Nephew, Inc.3
Xiangya Hospital of Central South University3
Amway (China) R&D Center2
Beijing Jishuitan Hospital2
Beijing Tsinghua Chang Gung Hospital2
Chinese PLA General Hospital2
Guang'anmen Hospital of China Academy of Chinese Medical Sciences2
Peking University Third Hospital2
Smith & Nephew Medical (Shanghai) Ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoarthritis66
Osteoarthritis, Knee12
Arthritis, Rheumatoid10
Pain6
Arthritis3
Femoral Neck Fractures3
Obesity3
Osteonecrosis3
Osteoporosis3
Hip Fractures2

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.